Seven out of 19 patients (36.8%) with the ITPA 94C>A mutation developed leukopenia; however, this mutation may not unequivocally increase the risk of developing adverse reactions to thiopurines. The gene discussed is ITPA; the disease is Decreased total leukocyte count.